Adjunct Associate Professor, Albany College of Pharmacy/Union University, Albany, New York; Clinical Pharmacy Specialist, Stratten VA Medical Center, Albany, New York To recognize the role of any ...
WEST LAFAYETTE, Ind. – A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. Purdue University innovators ...
(Reuters) - A panel of advisers to the Food and Drug Administration recommended on Tuesday that the agency no longer support the marketing of calcitonin salmon as a treatment for osteoporosis in ...
PHILADELPHIA, Feb. 14, 2011 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced completion of its global Phase III ORACAL trial testing the company's once-daily oral recombinant calcitonin for ...
OTTAWA, July 31, 2012 /CNW/ - Health Canada is informing Canadians that it is assessing the possibility of an increased risk of cancer with long-term use of the drug calcitonin. Calcitonin is a ...
Objective: To develop a method that estimates and compares the antifracture efficacy [relative risk reduction (RRR) and number needed to treat (NNT)] of various antiresorptive agents when fracture ...
—Oral Presentation at ASBMR 2012 Annual Meeting Shows Tarsa's Oral Calcitonin Tablet Achieved Efficacy Endpoint with Good Safety Profile— The Phase II trial evaluated the ability of Tarsa's oral ...
Data showed oral drug licensed from Unigene was as good as nasal spray calcitonin at improving BMD. Tarsa Therapeutics reported positive data from a Phase III study evaluating its once-daily oral ...
In X-linked hypophosphatemia, phosphate wasting results from increased circulating levels of fibroblast growth factor 23 (FGF-23). 1 Administration of calcitonin to a patient with oncogenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback